BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

556 related articles for article (PubMed ID: 16342345)

  • 1. Ventricular pacing vs dual chamber pacing in patients with persistent atrial fibrillation after atrioventricular node ablation: open randomized study.
    Petrac D; Radić B; Radeljić V; Hamel D; Filipović J
    Croat Med J; 2005 Dec; 46(6):922-8. PubMed ID: 16342345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of atrioventricular node ablation and pacing therapy on clinical course in patients with permanent atrial fibrillation and unstable ventricular tachycardia induced by rapid ventricular response: follow-up study.
    Petrac D; Radićc B; Radeljić V; Hamel D; Filipović J
    Croat Med J; 2005 Dec; 46(6):929-35. PubMed ID: 16342346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimizing ventricular pacing to reduce atrial fibrillation in sinus-node disease.
    Sweeney MO; Bank AJ; Nsah E; Koullick M; Zeng QC; Hettrick D; Sheldon T; Lamas GA;
    N Engl J Med; 2007 Sep; 357(10):1000-8. PubMed ID: 17804844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of the strategy of maintenance of sinus rhythm by antiarrhythmic drug therapy after ablation and pacing therapy in patients with paroxysmal atrial fibrillation.
    Brignole M; Menozzi C; Gasparini M; Bongiorni MG; Botto GL; Ometto R; Alboni P; Bruna C; Vincenti A; Verlato R;
    Eur Heart J; 2002 Jun; 23(11):892-900. PubMed ID: 12042011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of upgrading to biventricular pacing in patients with right ventricular pacing and congestive heart failure after atrioventricular junctional ablation for chronic atrial fibrillation.
    Valls-Bertault V; Fatemi M; Gilard M; Pennec PY; Etienne Y; Blanc JJ
    Europace; 2004 Sep; 6(5):438-43. PubMed ID: 15294269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of ventricular desynchronization by permanent para-Hisian pacing after atrioventricular node ablation in chronic atrial fibrillation: a crossover, blinded, randomized study versus apical right ventricular pacing.
    Occhetta E; Bortnik M; Magnani A; Francalacci G; Piccinino C; Plebani L; Marino P
    J Am Coll Cardiol; 2006 May; 47(10):1938-45. PubMed ID: 16697308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term survival after ablation of the atrioventricular node and implantation of a permanent pacemaker in patients with atrial fibrillation.
    Ozcan C; Jahangir A; Friedman PA; Patel PJ; Munger TM; Rea RF; Lloyd MA; Packer DL; Hodge DO; Gersh BJ; Hammill SC; Shen WK
    N Engl J Med; 2001 Apr; 344(14):1043-51. PubMed ID: 11287974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved cardiac function and quality of life following upgrade to dual chamber pacing after long-term ventricular stimulation.
    Höijer CJ; Brandt J; Willenheimer R; Juul-Möller S; Boström PA
    Eur Heart J; 2002 Mar; 23(6):490-7. PubMed ID: 11863352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between right ventricular pacing and atrial fibrillation burden and disease progression in patients with paroxysmal atrial fibrillation: the long-MinVPACE study.
    Veasey RA; Arya A; Silberbauer J; Sharma V; Lloyd GW; Patel NR; Sulke AN
    Europace; 2011 Jun; 13(6):815-20. PubMed ID: 21208945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left ventricular-based cardiac stimulation post AV nodal ablation evaluation (the PAVE study).
    Doshi RN; Daoud EG; Fellows C; Turk K; Duran A; Hamdan MH; Pires LA;
    J Cardiovasc Electrophysiol; 2005 Nov; 16(11):1160-5. PubMed ID: 16302897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcome of the atrioventricular node ablation and pacemaker implantation for symptomatic refractory atrial fibrillation.
    Tan ES; Rienstra M; Wiesfeld AC; Schoonderwoerd BA; Hobbel HH; Van Gelder IC
    Europace; 2008 Apr; 10(4):412-8. PubMed ID: 18272509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. Canadian Trial of Physiologic Pacing Investigators.
    Connolly SJ; Kerr CR; Gent M; Roberts RS; Yusuf S; Gillis AM; Sami MH; Talajic M; Tang AS; Klein GJ; Lau C; Newman DM
    N Engl J Med; 2000 May; 342(19):1385-91. PubMed ID: 10805823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Atrial Pacing Peri-ablation for Paroxysmal Atrial Fibrillation (PA3) Study: rationale and study design.
    Gillis AM
    Europace; 1999 Jan; 1(1):40-2. PubMed ID: 11220538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction.
    Sweeney MO; Hellkamp AS; Ellenbogen KA; Greenspon AJ; Freedman RA; Lee KL; Lamas GA;
    Circulation; 2003 Jun; 107(23):2932-7. PubMed ID: 12782566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment crossovers did not affect randomized treatment comparisons in the Mode Selection Trial (MOST).
    Hellkamp AS; Lee KL; Sweeney MO; Link MS; Lamas GA;
    J Am Coll Cardiol; 2006 Jun; 47(11):2260-6. PubMed ID: 16750693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ventricular pacing or dual-chamber pacing for sinus-node dysfunction.
    Lamas GA; Lee KL; Sweeney MO; Silverman R; Leon A; Yee R; Marinchak RA; Flaker G; Schron E; Orav EJ; Hellkamp AS; Greer S; McAnulty J; Ellenbogen K; Ehlert F; Freedman RA; Estes NA; Greenspon A; Goldman L;
    N Engl J Med; 2002 Jun; 346(24):1854-62. PubMed ID: 12063369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophysiological determinants of atrial fibrillation in sinus node dysfunction despite atrial pacing.
    De Sisti A; Attuel P; Manot S; Fiorello P; Halimi F; Leclercq JF
    Europace; 2000 Oct; 2(4):304-11. PubMed ID: 11194597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catheter ablation of atrial fibrillation versus atrioventricular junction ablation plus pacing therapy for elderly patients with medically refractory paroxysmal atrial fibrillation.
    Hsieh MH; Tai CT; Lee SH; Tsao HM; Lin YK; Huang JL; Chan P; Chen YJ; Kuo JY; Tuan TC; Hsu TL; Kong CW; Chang SL; Chen SA
    J Cardiovasc Electrophysiol; 2005 May; 16(5):457-61. PubMed ID: 15877612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrioventricular node ablation is not a prerequisite for cardiac resynchronization therapy in patients with chronic atrial fibrillation.
    Schütte F; Lüdorff G; Grove R; Kranig W; Thale J
    Cardiol J; 2009; 16(3):246-9. PubMed ID: 19437399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preserved left ventricular ejection fraction following atrioventricular junction ablation and pacing for atrial fibrillation.
    Chen L; Hodge D; Jahangir A; Ozcan C; Trusty J; Friedman P; Rea R; Bradley D; Brady P; Hammill S; Hayes D; Shen WK
    J Cardiovasc Electrophysiol; 2008 Jan; 19(1):19-27. PubMed ID: 17971146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.